Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

511.50INR
12:41pm IST
Change (% chg)

Rs5.55 (+1.10%)
Prev Close
Rs505.95
Open
Rs506.00
Day's High
Rs515.00
Day's Low
Rs505.15
Volume
1,862,619
Avg. Vol
5,760,131
52-wk High
Rs784.25
52-wk Low
Rs432.70

Chart for

About

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)

Overall

Beta: 0.07
Market Cap(Mil.): Rs1,232,884.00
Shares Outstanding(Mil.): 2,399.31
Dividend: 3.50
Yield (%): 0.68

Financials

  Industry Sector
P/E (TTM): -- 30.87 15.95
EPS (TTM): -- -- --
ROI: -- 14.31 15.19
ROE: -- 15.61 13.87

BRIEF-Sun Pharmaceutical Industries says unit gets U.S. FDA nod for new label for odomzo (sonidegib)

* Says one of co's units received approval from U.S. FDA for new label for odomzo (sonidegib) Source text - http://bit.ly/2f8WIsa Further company coverage:

20 Sep 2017

MEDIA-India's Sun Pharma expects FY18 revenues to decline - PTI in Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

04 Sep 2017

BRIEF-Sun Pharmaceutical Industries seeks shareholders' nod for re-appointment of Dilip S. Shanghvi as MD

* Seeks shareholders' nod for re-appointment of dilip s. Shanghvi as managing director

31 Aug 2017

RPT-ICRA ratings for Indian debt instruments-Aug 30

(Repeating to add more ratings) Aug 30 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of August 29, 2017. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: ---------------

31 Aug 2017

BUZZ-Indian pharma stocks see relief rally; index up 3 pct

** Shares of Indian pharmaceutical companies such as Cadila Healthcare, Lupin Ltd and Sun Pharmaceutical Industries gain between 4.10 pct and 8.9 pct

24 Aug 2017

BUZZ-India's Sun Pharma slumps to over 4-yr low on Q1 loss

** Sun Pharmaceutical Industries' shares drop as much as 3.8 pct to 432.7 rupees, their lowest since April 2013

14 Aug 2017

Sun Pharma reports first-quarter loss as generics business suffers

India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a surprise quarterly loss on Friday due to one-off legal costs and pressure over prices in its largest market, the United States, casting a shadow over its growth prospects.

11 Aug 2017

UPDATE 2-India's Sun Pharma reports Q1 loss as generics business suffers

* Expects profit margin to improve in second-half of 2018 (Adds Managing Director comments from conference call)

11 Aug 2017

BRIEF-Sun Pharma says co on track to achieve $300 mln synergies from Ranbaxy deal

* MD Dilip Shanghvi says on track to achieve $300 million synergies from Ranbaxy deal

11 Aug 2017

India's Sun Pharma posts surprise loss in June-qtr

Aug 11 India's largest drugmaker Sun Pharmaceutical Industries posted a surprise loss in the first quarter.

11 Aug 2017

Earnings vs. Estimates